{"id":226772,"date":"2017-07-10T03:52:21","date_gmt":"2017-07-10T07:52:21","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/campus-innovators-receive-grants-to-advance-research-davis-enterprise.php"},"modified":"2017-07-10T03:52:21","modified_gmt":"2017-07-10T07:52:21","slug":"campus-innovators-receive-grants-to-advance-research-davis-enterprise","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/campus-innovators-receive-grants-to-advance-research-davis-enterprise.php","title":{"rendered":"Campus innovators receive grants to advance research &#8211; Davis Enterprise"},"content":{"rendered":"<p><p>    UC Davis announced last week the recipients of nine    proof-of-concept grants totaling $328,000 for campus innovators    to advance their research and technologies toward    commercialization.  <\/p>\n<p>    These grants and the associated review process are managed by    UCD Venture Catalyst through the Science Translation and    Innovative Research, or STAIR, grant program, which is in its    fourth year, and the newly launched Data, Informatics and    Application Launch, or DIAL, grant program.  <\/p>\n<p>    It remains the responsibility of public universities like UC    Davis, to fulfill their societal mission of generating impact    from research, by facilitating the translation of faculty and    student research into meaningful products and services that    enrich the human experience, said Dushyant Pathak, associate    vice chancellor for research and executive director of Venture    Catalyst.  <\/p>\n<p>    Through our successful STAIR grant program and the newly    launched DIAL grants, we are enabling our most innovative    campus researchers to map a more effective path from their    scientific and engineering breakthroughs to the commercial    sphere.  <\/p>\n<p>    STAIR grant recipients    The STAIR grant program provides awards of up to $50,000 per    grant recipient to help campus innovators demonstrate    proof-of-concept and commercial feasibility of their    technologies. A total of 30 applications were received this    year.  <\/p>\n<p>    Six award recipients were selected to receive grants following    a multistage review process involving external industry    experts, investors and entrepreneurs that evaluated each    application based on its market potential, technical merit and    ability to achieve identified commercialization milestones with    the funds requested.  <\/p>\n<p>    This years STAIR grant recipients are:  <\/p>\n<p>    * Johnathon Anderson, assistant professor,    Stem Cell Research Program: Anderson and his team have    developed a novel drug candidate platform for inflammatory    diseases that offers the beneficial aspects of stem cell    therapeutics with fewer hurdles to clinical development.  <\/p>\n<p>    * Paul Henderson, associate adjunct professor,    department of internal medicine: Henderson and his team are    developing an add-on chemotherapy drug that increases the    effectiveness of existing treatment regimens for advanced    bladder cancer. Their innovation, an orally bioavailable drug,    combines anti-inflammatory and anti-angiogenic properties.  <\/p>\n<p>    * Lee Miller, associate professor, Center for    Mind and Brain: Miller and his team have developed a powerful    electroencephalogram diagnostic that provides a rapid and    comprehensive assessment of the functional health of the    auditory system, including how speech is processed at different    levels and how these levels interact. Their innovation is    expected to enable individualized assessments of hearing loss    and improve the performance of assistive listening devices.  <\/p>\n<p>    * David Olson, assistant professor, department    of chemistry: Olson and his team have discovered how to    decouple the beneficial effects of neuroplasticity-promoting    compounds from their deleterious hallucinogenic and    psychostimulant effects in order to develop more effective drug    therapies for various neurological disorders.  <\/p>\n<p>    * Lin Tian, assistant professor, department of    biochemistry and molecular medicine: Tian and her team have    developed a novel technology for drug discovery involving    G-protein-coupled receptors. Their innovation directly tackles    GPCR confrontational dynamics in living cells and organisms,    providing a novel platform for rigorous high-throughput    cell-based screening and validation.  <\/p>\n<p>    * Yu-Jui (Yvonne) Wan, vice chair for    research, department of pathology and laboratory medicine: Wan    and her team are developing a bio-encapsulation process using    yeast to deliver retinoic acid and a short-chain fatty acid    with histone deacetylase inhibitory properties that benefit the    liver and intestine  offering the potential to help prevent    and treat metabolic-associated diseases and cancer.  <\/p>\n<p>    DIAL grant recipients    The DIAL grant program is a pilot program structured similarly    to the STAIR grant program, which targets commercial    opportunities in software, informatics and data science.  <\/p>\n<p>    This program is enabled by funding provided by the State of    California under Assembly Bill AB 2664. Passed in 2016, this    legislation authorizes one-time funding of $2.2 million to each    of the 10 University of California campuses with the objective    of expanding innovation and entrepreneurship programs on each    campus.  <\/p>\n<p>    Three DIAL grant recipients were selected following a review    process modeled on the STAIR grant program, based on each    projects market potential, technical merit and ability to    achieve identified commercialization milestones with the funds    requested.  <\/p>\n<p>    The DIAL grant award recipients are:  <\/p>\n<p>    * Petr Janata, professor, department of    psychology: Janata has invented an online platform that allows    users to document and share personal memories they associate    with specific pieces of music.  <\/p>\n<p>    Janatas technology platform leverages his research in the    field of cognitive neuroscience and the psychology of music to    enable a number of life enriching applications linking music,    memory and interpersonal interactions.  <\/p>\n<p>    * Nelson Max, distinguished professor,    department of computer science: Max and his team have developed    a novel system for use in emergency response training where    emergency scenarios can be added to real world environments.    His invention uses a quadcopter camera that will add    computer-generated artificial reality graphic image components    to a computer screen.  <\/p>\n<p>    * Lisa Miller, professor, department of    anatomy, physiology & cell biology: Miller and her team    have invented a gaming app to teach nutrition concepts,    practice food-choice skills, build nutritional literacy and    promote healthy behavior-change in adults to combat poor    dietary habits.  <\/p>\n<\/p>\n<p>     UC Davis News  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more: <\/p>\n<p><a target=\"_blank\" href=\"https:\/\/www.davisenterprise.com\/local-news\/ucd\/campus-innovators-receive-grants-to-advance-research\/\" title=\"Campus innovators receive grants to advance research - Davis Enterprise\">Campus innovators receive grants to advance research - Davis Enterprise<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> UC Davis announced last week the recipients of nine proof-of-concept grants totaling $328,000 for campus innovators to advance their research and technologies toward commercialization.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/campus-innovators-receive-grants-to-advance-research-davis-enterprise.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-226772","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/226772"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=226772"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/226772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=226772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=226772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=226772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}